Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Gains from Investment Securities (2021 - 2025)

Silence Therapeutics' Gains from Investment Securities history spans 5 years, with the latest figure at $10.2 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 43.15% to $10.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.1 million, a 151.6% increase, with the full-year FY2025 number at $5.9 million, down 66.2% from a year prior.
  • Gains from Investment Securities hit $10.2 million in Q4 2025 for Silence Therapeutics, up from $423551.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for SLN hit a ceiling of $13.6 million in Q4 2022 and a floor of -$109141.2 in Q3 2024.
  • Historically, Gains from Investment Securities has averaged $3.8 million across 5 years, with a median of $423551.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 51.68% in 2023 and later soared 488.08% in 2025.
  • Tracing SLN's Gains from Investment Securities over 5 years: stood at $3.6 million in 2021, then soared by 275.1% to $13.6 million in 2022, then tumbled by 51.68% to $6.6 million in 2023, then grew by 8.65% to $7.1 million in 2024, then surged by 43.15% to $10.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for SLN at $10.2 million in Q4 2025, $423551.0 in Q3 2025, and $363643.0 in Q2 2025.